Penumbra, Inc. Common Stock

Financials

영업활동으로 인한 현금 -33.24 M9.5 M-55.66 M97.33 M168.48 M238.66 M 276.66 M 투자 활동으로 인한 현금 -104.15 M-21.73 M54.79 M-16.08 M77.62 M-404.59 M -434.72 M 재무활동으로 인한 현금 134.92 M836 K11.62 M16.2 M-87.01 M26.53 M 21.92 M 잉여 현금 흐름 -33.24 M9.5 M-55.66 M97.33 M168.48 M174.93 M 212.73 M

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend.

PEN

Financials

Penumbra, Inc. Common Stock

뉴스

Baron Health Care Fund Q1 2026 Portfolio Activity

Diamond Hill Long-Short Strategy Q1 2026 Portfolio Movers: Gains, Drags, And Trades

Penumbra (PEN) Misses Q1 Earnings Estimates

ALC vs. PEN: Which Stock Should Value Investors Buy Now?

NovoCure Stock Shows Strength With RS Upgrade; Investors Should Watch For Next Entry

3 Reasons Why Penumbra (PEN) Is a Great Growth Stock

Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts

Here's Why Penumbra (PEN) is a Strong Growth Stock

3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)

Penumbra (PEN) Down 1.6% Since Last Earnings Report: Can It Rebound?

Reasons to Retain Penumbra Stock in Your Portfolio for Now

Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates